Biotrofix's mission is to provide the highest-quality preclinical efficacy contract services for CNS, vascular and other diseases to our Clients, who include biotech and pharmaceutical companies, as well as academic investigators.|
Details: Biotrofix, Inc. was founded by Dr. Seth P. Finklestein and Dr. JingMei Ren, who have over 25 and 10 years of experience, respectively, in this field, in both academic and industrial settings.
Biotrofix is located in well-equipped laboratories, with an AAALAC-accredited animal facility. Biotrofix performs its services on a strictly fee-for-service basis, and takes no intellectual property rights on the work it does for clients.
A comprehensive report is submitted to clients at the end of each study. Biotrofix currently provides contract services for several leading biotech and global pharmaceutical companies.
Category: Clinical Trials